Novogen (NASDAQ:KZIA – Get Free Report) was upgraded by analysts at Wall Street Zen to a “sell” rating in a research note issued on Saturday. A number of other equities analysts have also weighed in on KZIA. Maxim Group reaffirmed a “buy” rating and issued a …